Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)
Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%
Zoetis cash
Cash and short-term investments held at the end of each period.
Zoetis's cash was $1.68B at Jun 30, 2026. For fiscal 2025 it was $2.45B, up 15.9% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $3.60B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.45B | +15.9% |
| FY2024 | Dec 31, 2024 | $2.11B | +3.6% |
| FY2023 | Dec 31, 2023 | $2.04B | -43.0% |
| FY2022 | Dec 31, 2022 | $3.58B | +2.8% |
| FY2021 | Dec 31, 2021 | $3.49B | -3.3% |
| FY2020 | Dec 31, 2020 | $3.60B | +86.3% |
| FY2019 | Dec 31, 2019 | $1.93B | +13.7% |
| FY2018 | Dec 31, 2018 | $1.70B | +8.8% |
| FY2017 | Dec 31, 2017 | $1.56B | +115.1% |
| FY2016 | Dec 31, 2016 | $727.00M | -37.0% |
| FY2015 | Dec 31, 2015 | $1.15B | +30.8% |
| FY2014 | Dec 31, 2014 | $882.00M | +44.6% |
| FY2013 | Dec 31, 2013 | $610.00M | +92.4% |
| FY2012 | Dec 31, 2012 | $317.00M | +301.3% |
| FY2011 | Dec 31, 2011 | $79.00M | +25.4% |
| FY2010 | Dec 31, 2010 | $63.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.68B | +2.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.94B | +8.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.45B | +15.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.08B | +21.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.63B | +3.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.78B | -9.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.11B | +3.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.71B | -2.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.57B | -8.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.98B | -6.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.04B | -43.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.75B | -30.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.72B | -35.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.11B | -32.7% |
| Q4 FY2022 | Dec 31, 2022 | $3.58B | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.51B | -23.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.65B | -27.5% |
| Q1 FY2022 | Mar 31, 2022 | $3.14B | -13.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.49B | -3.3% |
| Q3 FY2021 | Sep 30, 2021 | $3.27B | -10.4% |
| Q2 FY2021 | Jun 30, 2021 | $3.66B | +9.1% |
| Q1 FY2021 | Mar 31, 2021 | $3.60B | +84.6% |
| Q4 FY2020 | Dec 31, 2020 | $3.60B | +86.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.65B | +100.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.35B | +88.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.95B | +8.8% |
| Q4 FY2019 | Dec 31, 2019 | $1.93B | +13.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.83B | +31.3% |
| Q2 FY2019 | Jun 30, 2019 | $1.78B | +14.2% |
| Q1 FY2019 | Mar 31, 2019 | $1.79B | +8.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.70B | +8.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.39B | -29.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.56B | +121.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.65B | +163.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.56B | +115.1% |
| Q3 FY2017 | Oct 1, 2017 | $1.98B | +204.3% |
| Q2 FY2017 | Jul 2, 2017 | $705.00M | – |
| Q1 FY2017 | Apr 2, 2017 | $629.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $727.00M | – |
| Q3 FY2016 | Oct 2, 2016 | $651.00M | – |
See a number that looks wrong?